Simplex Trading’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.9K Buy
27,000
+23,900
+771% +$47.9K ﹤0.01% 5556
2025
Q4
$4.25K Sell
3,100
-13,200
-81% -$17.4K ﹤0.01% 7516
2025
Q3
$20K Buy
16,300
+6,800
+72% +$8.11K ﹤0.01% 7310
2025
Q2
$10K Sell
9,500
-300
-3% -$399 ﹤0.01% 7286
2025
Q1
$14K Buy
9,800
+6,300
+180% +$11.9K ﹤0.01% 6822
2024
Q4
$7K Sell
3,500
-52,200
-94% -$129K ﹤0.01% 7387
2024
Q3
$155K Sell
55,700
-13,000
-19% -$34.7K ﹤0.01% 4774
2024
Q2
$160K Sell
68,700
-2,000
-3% -$5.9K ﹤0.01% 4862
2024
Q1
$316K Buy
70,700
+69,400
+5,338% +$290K ﹤0.01% 4322
2023
Q4
$4K Sell
1,300
-3,700
-74% -$10.5K ﹤0.01% 7927
2023
Q3
$15K Buy
5,000
+1,500
+43% +$6.57K ﹤0.01% 6855
2023
Q2
$17K Sell
3,500
-12,600
-78% -$68.2K ﹤0.01% 6909
2023
Q1
$79K Sell
16,100
-23,700
-60% -$152K ﹤0.01% 5419
2022
Q4
$250K Buy
39,800
+24,900
+167% +$231K ﹤0.01% 3944
2022
Q3
$160K Sell
14,900
-2,800
-16% -$38K ﹤0.01% 4909
2022
Q2
$201K Buy
17,700
+8,400
+90% +$74.6K ﹤0.01% 4588
2022
Q1
$84K Buy
9,300
+2,200
+31% +$22.9K ﹤0.01% 6388
2021
Q4
$105K Buy
7,100
+5,500
+344% +$97K ﹤0.01% 6176
2021
Q3
$42K Hold
1,600
﹤0.01% 7711
2021
Q2
$41K Buy
1,600
+1,442
+913% +$41.1K ﹤0.01% 7886
2021
Q1
$557K Sell
158
-6
-4% -$202 ﹤0.01% 3212
2020
Q4
$413K Buy
164
+155
+1,722% +$5.05K ﹤0.01% 3677
2020
Q3
$33K Sell
9
-53
-85% -$2K ﹤0.01% 5978
2020
Q2
$265K Buy
62
+49
+377% +$1.77K ﹤0.01% 3672
2020
Q1
$25K Sell
13
-281
-96% -$6.69K ﹤0.01% 5757
2019
Q4
$763K Buy
294
+223
+314% +$6.14K ﹤0.01% 2333
2019
Q3
$193K Buy
71
+33
+87% +$940 ﹤0.01% 3590
2019
Q2
$102K Sell
38
-2
-5% -$56 ﹤0.01% 4168
2019
Q1
$115K Buy
40
+36
+900% +$1.04K ﹤0.01% 4198
2018
Q4
$10K Buy
+4
New +$106 ﹤0.01% 5826

Other funds holding ALLO